TLR2 and hepatocellular carcinoma: Nischalke et al. (2012) reported that TLR2 -196 to -174 del/ ins polymorphism increased the risk of HCC in patients with HCV (genotype 1) infection, and -196 to -174 del affected the HCV viral load.